[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100655924":3},{"organization":4,"outcomesModule":7,"designInfo":27,"detailedDescription":26,"studyPopulation":26,"armGroups":33,"interventions":41,"overallOfficials":26,"centralContacts":52,"locations":58,"responsibleParty":76,"collaborators":78,"id":81,"slug":82,"hasResults":83,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":26,"eligibilityCriteria":87,"healthyVolunteers":83,"sex":88,"minAge":89,"maxAge":26,"enrollmentInfo":90,"targetDuration":26,"studyType":93,"phases":94,"briefSummary":96,"conditions":97,"keywords":26,"overallStatus":100,"whyStopped":26,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"Colgate Palmolive","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":26},[9],{"measure":10,"description":11,"timeFrame":12},"Enamel Lesions per BlueCheck","Number of enamel lesions counted after using BlueCheck","Baseline, 4 weeks, and 12 weeks",[14,17,20,23],{"measure":15,"description":16,"timeFrame":12},"Self-perceived reactions to BlueCheck application","Questionnaire clinician and subject feedback on the BlueCheck application",{"measure":18,"description":19,"timeFrame":12},"Enamel Lesions per Xray","Number and location of visible enamel lesions on Xray",{"measure":21,"description":22,"timeFrame":12},"Enamel lesions per intraoral camera","Number and location of enamel lesions detected by an intraoral camera using a caries mode",{"measure":24,"description":25,"timeFrame":12},"White spots","Number and location of visible white spots per examiner's identification",null,{"allocation":28,"interventionModel":29,"interventionModelDescription":26,"primaryPurpose":30,"observationalModel":26,"timePerspective":26,"maskingInfo":31},"NA","SINGLE_GROUP","DIAGNOSTIC",{"masking":32,"maskingDescription":26,"whoMasked":26},"NONE",[34],{"label":35,"type":36,"description":37,"interventionNames":38},"Test Group","EXPERIMENTAL","This is a monadic study with one arm. All subjects will receive the intervention.",[39,40],"Device: BlueCheck","Drug: Prevident 5000ppm Booster Plus Toothpaste",[42,47],{"type":43,"name":44,"description":45,"armGroupLabels":46,"otherNames":26},"DEVICE","BlueCheck","BlueCheck, a carious lesion detection formulated device, will be used to track enamel lesions for patients who are newly receiving a high fluoride toothpaste.",[35],{"type":48,"name":49,"description":50,"armGroupLabels":51,"otherNames":26},"DRUG","Prevident 5000ppm Booster Plus Toothpaste","This clinical study is testing the ability of BlueCheck to detect enamel lesions over time. In order to show changes in lesions, subjects will be prescribed Prevident 5000ppm Booster Plus Toothpaste",[35],[53],{"name":54,"role":55,"phone":56,"phoneExt":26,"email":57},"Zerita Buchanan, DDS, MPH","CONTACT","404-289-7311","infopatient@dentaldreams.net",[59],{"facility":60,"status":26,"city":61,"state":62,"zip":63,"country":64,"countryCode":65,"cosmosGeoPoint":66,"geoPoint":71,"contacts":72},"Dental Dreams, LLC","Lithonia","Georgia","30038","United States","US",{"type":67,"coordinates":68},"Point",[69,70],-84.10519,33.71233,{"lat":70,"lon":69},[73,74],{"name":54,"role":55,"phone":56,"phoneExt":26,"email":57},{"name":54,"role":75,"phone":26,"phoneExt":26,"email":26},"PRINCIPAL_INVESTIGATOR",{"type":77,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[79],{"name":60,"class":80},"UNKNOWN","100655924","phase-4-enamel-lesion-detection-with-new-dx-tool-100655924",false,"NCT07819370","Enamel Lesion Detection With New DX Tool","Early Enamel Lesion Detection and Management With a New Diagnostic Tool","Inclusion Criteria:\n\n* Signed Informed Consent\u002FAssent Form.\n* Male and female subjects aged 13 years or older.\n* Availability for the duration of the study.\n* Good general health and good oral health based on the opinion of the study investigator.\n* Subjects must have active enamel lesions and no cavities requiring immediate restoration in the mouth.\n* Subjects must be candidates for high fluoride toothpaste treatment.\n\nExclusion Criteria:\n\n* Subjects with fixed or removable orthodontic appliances or removable partial dentures.\n* Obvious signs of periodontal disease or any condition that the dental examiner considers exclusionary from the study.\n* Cavities.\n* Concurrent participation in another oral clinical study.\n* Self-reported pregnant and\u002For lactating women, or those planning to become pregnant during the study.\n* History of allergies or sensitivity to personal care consumer products or their ingredients.\n* Medical condition which requires premedication prior to dental visits\u002Fprocedure.\n* Significant oral soft tissue pathology, excluding plaque-induced gingivitis.\n* Dental prophylaxis within 30 days prior to study start.\n* Subjects who must receive dental treatment during the study dates.\n* Immunocompromised individuals (HIV, AIDS, immunosuppressive drug therapy).\n* Use of smokeless tobacco, vaping, or e-cigarettes or suspected substance abuse.\n* Current smokers (if former smoker, should have stopped at least 1 month prior to Visit 1).\n* Subjects who have an infectious disease and\u002For other blood borne diseases (Hepatitis series, HIV, tuberculosis).","ALL","13 Years",{"count":91,"type":92},5,"ESTIMATED","INTERVENTIONAL",[95],"PHASE4","The primary objective of this 12-week study is to test BlueCheck's ability to identify enamel lesions consistently, and its ability to track changes in these lesions over time.",[98,99],"Enamel Lesions","Caries","NOT_YET_RECRUITING","2026-09-10",{"date":103,"type":104},"2026-09-14","ACTUAL",{"date":106,"type":92},"2026-09-15",{"date":108,"type":92},"2026-12-20",{"name":5,"class":6},1]